Women who cleared BV had decreased frequencies of CD38+ CD4+ T cells (p = 0.0423, mean difference of 1%) and HLADR+ CD4+ T cells (p = 0.0294, mean difference of 1%) at 12-weeks post-MDZ compared to baseline. The gene discussed is CD38; the disease is bacterial vaginosis.